Low Pressure Liquid Chromatography Market Size

Global Low-Pressure Liquid Chromatography Market Overview

Low-Pressure Liquid Chromatography Market Size was valued at USD 5.5 Billion in 2022. The Low-Pressure Liquid Chromatography market industry is projected to grow from USD 5.9 Billion in 2023 to USD 10.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.30% during the forecast period (2023 - 2032). Increased use of cutting-edge technology in clinical laboratories and the use of protein-based vaccinations, are the key market drivers enhancing the market growth. 

Component: Secondary Research, Primary Research, MRFR Database and Analyst Review

Low-Pressure Liquid Chromatography Market Trends

• Increasing investment in drug development is driving the market growth

The market for low-pressure liquid chromatography is being driven by rising investments in pharmaceutical development, an increase in R&D facilities, modernization of lab facilities, and favourable government regulatory requirements. Additionally, market participants engage in business activities like joint ventures, product launches, service agreements, and affiliations with both public and private research organisations. The market for low-pressure liquid chromatography is anticipated to expand over time as a result of the government authorities investing more money in the infrastructure for conducting research. The infrastructure for clinical research and medication development is being modernised and technologically advanced by government agencies in nations including the US, India, China, and Japan. These elements are the market catalysts for low-pressure liquid chromatography and are anticipated to expand over the forecast period.

The protein-based vaccinations are still in the early stages of clinical testing but have great promise as medicines. The market for low-pressure liquid chromatography is being driven by the rising interest in the development of vaccines based on peptides. The peptide-based medications are affordable, secure, and efficient. Additionally, employing protein subunits, pharmaceutical companies are creating treatments for acellular pertussis and hepatitis-B. Additionally, during the COVID-19 outbreak, scientists from all around the world were eager to create protein-based subunit vaccines. A protein-based vaccine to treat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was created by UK researchers in November 2020. These vaccines will eventually replace mRNA-based vaccinations in use. Companies like Sanofi (France) and GSK (UK) are working together to produce the COVID-19 recombinant protein vaccine. The third phase of the clinical study for the COVID-19 recombinant vaccine was to begin, according to the company's announcement in May 2021. The business is examining the outcomes of the earlier clinical studies for the recombinant protein vaccine, and it anticipates receiving vaccination approval by the fourth quarter of 2021. The creation of such a cutting-edge vaccination is anticipated to fuel the expansion of the low-pressure liquid chromatography market over the forecasted period.

Government organisations in the United States, Europe, and Asia Pacific are continually investing in and providing grants and cash for the development of liquid chromatography as a result of growing public knowledge of this technique. This will broaden the potential for the creation of new chromatographic technologies, which will promote the expansion of the  liquid chromatography market. Government funding for medical research is increasing, which is fueling demand for liquid chromatography equipment. This element will probably influence the market. The Asia Pacific region's investments in biomedical businesses are a significant driver of the  liquid chromatography market's expansion. The worldwide liquid chromatography market is therefore anticipated to grow as a result of increasing government backing and associated organisations. Additionally, the use in drug development and quality assessment of pharmaceutical products is anticipated to drive market expansion. Additionally, the market's growth is moderated during the anticipated period by the accessibility of some liquid chromatography instruments in labs and the growing significance of chromatography tests in the medication approval process. The development of generics and CROS together with the therapeutic conversion to new biological entities will have a beneficial impact on the growth rate of the liquid chromatography devices market in the future. Thus, driving the Low-Pressure Liquid Chromatography market revenue.

Low-Pressure Liquid Chromatography Market Segment Insights

Low-Pressure Liquid Chromatography Component Insights

The Low-Pressure Liquid Chromatography market segmentation, based on component, includes instruments, consumables, and services. Instruments segment accounted for the largest revenue share in 2022. It is a specific kind of tool used for precise work. Chromatographic separations are carried out using these tools. Products including pumps, detectors, columns, and flow cells are among the instruments.

Low-Pressure Liquid Chromatography End User Insights

The Low-Pressure Liquid Chromatography market segmentation, based on end user, includes pharmaceutical companies, biotechnology companies, research laboratories, and academic institution. Pharmaceutical companies segment dominated the Low-Pressure Liquid Chromatography market in 2022. It is a particular kind of business that develops, investigates, and manufactures both generic and name-brand drugs. Low-pressure liquid chromatography equipment is used by pharmaceutical companies to develop new generic and specialised medications.

Figure 1:  Low-Pressure Liquid Chromatography Market, by End User, 2022 & 2032 (USD Billion)

Component: Secondary Research, Primary Research, MRFR Database and Analyst Review

Low-Pressure Liquid Chromatography Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Low-Pressure Liquid Chromatography Market dominated this market in 2022 (45.80%). This is due to increased investment in adeno-associated viral therapy, increased use of precise and effective liquid chromatography, and increased funding for the creation of new products based on gene therapy. The market for low-pressure liquid chromatography products is also quickening due to the region's growing elderly population and rising demand for diagnostic testing. The market for low-pressure liquid chromatography in North America is anticipated to be driven by these factors. Further, the U.S. Low-Pressure Liquid Chromatography market held the largest market share, and the Canada Low-Pressure Liquid Chromatography market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2:  LOW-PRESSURE LIQUID CHROMATOGRAPHY MARKET SHARE BY REGION 2022 (USD Billion)

Component: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Low-Pressure Liquid Chromatography market accounted for the healthy market share in 2022. The Europe low-pressure liquid chromatography market is being driven by the growing use of gene therapy in the area. Further, the German Low-Pressure Liquid Chromatography market held the largest market share, and the U.K Low-Pressure Liquid Chromatography market was the fastest growing market in the European region

The Asia Pacific Low-Pressure Liquid Chromatography market is expected to register significant growth from 2023 to 2032. The advent of new diseases, the rising elderly population, rising spending in research facilities, and supportive governmental policies are to blame for this. In the estimated time frame, these variables are anticipated to fuel the market need for low-pressure liquid chromatography. Additionally, rising investment to support current clinical studies and drug research is expected to speed up the region's sales of low-pressure liquid chromatography. Moreover, China’s Low-Pressure Liquid Chromatography market held the largest market share, and the Indian Low-Pressure Liquid Chromatography market was the fastest growing market in the Asia-Pacific region.

Low-Pressure Liquid Chromatography Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Low-Pressure Liquid Chromatography market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Low-Pressure Liquid Chromatography industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Low-Pressure Liquid Chromatography industry to benefit clients and increase the market sector. In recent years, the Low-Pressure Liquid Chromatography industry has offered some of the most significant advantages to medicine. Major players in the Low-Pressure Liquid Chromatography market, including Novasep, LEWA GmbH, Biolinx Labsystems, Bio-Rad Laboratories Inc., Danaher Corporation, and Nilsan Nishotech Systems Pvt. Ltd., are attempting to increase market demand by investing in research and development operations.

Danaher Corp. (Danaher) develops, produces, and sells industrial, commercial, professional, and medical goods and services. A wide range of testing equipment, communications solutions, water quality systems, medical diagnostic solutions, life science research tools, professional microscopes, product identification solutions, sustainable packaging design solutions, automation solutions, and sensors and controls solutions are all available. In Europe, Australia, Asia, and the Americas, the corporation has facilities for manufacturing, sales, distribution, service, and administration. Through direct sales representatives and independent distributors, the company reaches customers throughout the Americas, Europe, the Middle East, Africa, and Asia-Pacific with its products. Washington, DC, in the US, serves as the company's headquarters. In order to increase its knowledge of low-pressure liquid chromatography technology, Danaher Corporation (US) purchased General Electric's Healthcare Life Sciences Biopharma Business in December 2019. Purification is a feature of GE's KTAprocess, a low-pressure liquid chromatography system. The purchase broadened the business's offering in the low-pressure liquid chromatography sector.

One of the top producers and providers of low-pressure liquid chromatography equipment and supplies is Bio-Rad Laboratories, Inc. (US). The BioLogic LP low-pressure chromatography system from Bio-Rad Laboratories, Inc. (US) is used in particular for the purification of biomolecules. Because of its small size, the device requires less installation area. For the purpose of detecting proteins and nucleic acids, the device has 254 and 280 nm filters built in. A conductivity cell is also included in the system to track gradient development. The dual-channel peristaltic pump, which is integrated with the low-pressure liquid chromatography system, generates a back pressure of 30 psi. The company sells a variety of accessories, such as the BioFrac Fraction Collector, Model 2110 Fraction Collector, Econo Gradient Pump, Biologic LP Valves, and Biologic LP Data View Software.

Key Companies in the Low-Pressure Liquid Chromatography market include

• Novasep


• LEWA GmbH


• Biolinx Labsystems


• Bio-Rad Laboratories Inc.


• Danaher Corporation


• Nilsan Nishotech Systems Pvt. Ltd.

Low-Pressure Liquid Chromatography Industry Developments

July 2022:In conjunction with scientists at the Plant Protein Innovation Centre (PPIC) at the University of Minnesota, Waters Corporation has announced that it would contribute both technology and experience to help improve the study of plant-based proteins. To create a methodology for analysing the amino acid composition of plant-based proteins using a Waters ACQUITYTM Premier UPLC System, Waters experts will collaborate with PPIC researchers. Waters is the first manufacturer of analytical instruments to join the PPIC, a preeminent interdisciplinary research centre devoted to the study of plant and alternative proteins.

Low-Pressure Liquid Chromatography Market Segmentation

Low-Pressure Liquid Chromatography Component Outlook

• Instruments


• Consumables


• Services

Low-Pressure Liquid Chromatography End User Outlook

• Pharmaceutical Companies


• Biotechnology Companies


• Research Laboratories


• Academic Institution

Low-Pressure Liquid Chromatography Regional Outlook

• North America


• US


• Canada


• Europe


• Germany


• France


• UK


• Italy


• Spain


• Rest of Europe


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America